Clinical Trial Update: Medpulser Electroporation With Bleomycin Study to Treat Anterior Head and Neck Squamous Cell Carcinoma [Phase 3]

View source ↗

Summary

Phase 3 trial update for Medpulser electroporation with bleomycin in head and neck cancer has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Drugs mentioned

• Bleomycin (bleomycin)
• Medpulser

Snippet

Sponsor: Inovio Pharmaceuticals | Conditions: Head and Neck Cancer | Phase 3 | Status: TERMINATED